Ascendis Pharma Endocrinology Division A/s
Clinical trials sponsored by Ascendis Pharma Endocrinology Division A/s, explained in plain language.
-
New study tracks safety of growth hormone drug in kids over time
Disease control Recruiting nowThis study follows 500 children with growth hormone deficiency who are already taking lonapegsomatropin. Researchers will monitor for long-term risks like cancer and diabetes over several years. The goal is to better understand the drug's safety in everyday use.
Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated May 17, 2026 10:08 UTC
-
New study tracks Real-World effects of growth hormone drug in kids
Knowledge-focused Recruiting nowThis study follows about 900 children with growth hormone deficiency who are already taking SKYTROFA. Researchers will track side effects and measure how close children get to normal adult height. The goal is to see how well the drug works in everyday medical practice.
Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Knowledge-focused
Last updated May 17, 2026 10:10 UTC